CareDx and Omada Health Compared: Which Medical Stock Stands Out?

A head-to-head look at the financial performance, growth, and outlook of these two small-cap healthcare companies.

Apr. 15, 2026 at 9:34am by

Got story updates? Submit your updates here. ›

A high-end, photorealistic studio still-life featuring a set of premium medical diagnostic tools and devices arranged elegantly on a clean, monochromatic background, conceptually representing the advanced technology behind Omada Health and CareDx's virtual care solutions.Advanced medical technology powers the innovative virtual care solutions of Omada Health and CareDx, two small-cap companies aiming to transform chronic disease management.San Francisco Today

Omada Health (NASDAQ:OMDA) and CareDx (NASDAQ:CDNA) are both small-cap medical companies, but which is the better investment? This analysis compares the two firms across key metrics like revenue, earnings, profitability, valuation, and analyst recommendations to determine which stock is the more favorable pick.

Why it matters

Chronic diseases like diabetes, obesity, and musculoskeletal conditions are major cost drivers for employers, health plans, and the overall healthcare system. Innovative virtual care companies like Omada and CareDx are aiming to manage these conditions more effectively and cost-efficiently through technology-enabled programs.

The details

Omada Health and CareDx have both seen strong revenue growth in recent years, with Omada's sales increasing 38% in 2024 and CareDx's rising 57% in Q1 2025. Omada has a higher net dollar retention rate, suggesting better customer loyalty. However, CareDx has a more profitable business model, with higher net margins, return on equity, and return on assets. Analysts are also more bullish on Omada, with a 73.65% average upside target compared to 55.04% for CareDx.

  • Omada Health reported full-year 2024 results in March 2025.
  • CareDx reported Q1 2025 results in April 2025.

The players

Omada Health

A virtual care company that offers digital programs to help manage chronic conditions like diabetes, obesity, and musculoskeletal issues.

CareDx, Inc.

A diagnostic solutions provider for transplant patients, offering products like AlloSure Kidney, AlloMap Heart, and AlloSeq cfDNA.

Got photos? Submit your photos here. ›

The takeaway

While both Omada Health and CareDx are innovative healthcare companies addressing important chronic conditions, the analysis suggests Omada may be the more compelling investment at this time given its stronger customer metrics, analyst sentiment, and growth trajectory.